Inventor · disambiguated record
Andrew Carr
Also filed as: CARR ANDREW · CARR ANDREW DAVID
19 granted patents·3 pending applications·175 citations·filing 2005–2025
94Inventor score
Top patents by PatentIndex Score
22 records- 0197US11136305B2Nicotine salts, co-crystals, and salt co-crystal complexesREYNOLDS TOBACCO CO R·Filed 2020·Granted Oct 5, 2021·7 cites·13 claims
- 0297US9738622B2Nicotine salts, co-crystals, and salt co-crystal complexesREYNOLDS TOBACCO CO R·Filed 2015·Granted Aug 22, 2017·72 cites·4 claims
- 0395US10065952B2Valbenazine salts and polymorphs thereofNEUROCRINE BIOSCIENCES INC·Filed 2016·Granted Sep 4, 2018·30 cites·17 claims
- 0494US9896429B2Nicotine salts, co-crystals, and salt co-crystal complexesREYNOLDS TOBACCO CO R·Filed 2015·Granted Feb 20, 2018·10 cites·7 claims
- 0593US10556880B2Nicotine salts, co-crystals, and salt co-crystal complexesREYNOLDS TOBACCO CO R·Filed 2017·Granted Feb 11, 2020·13 cites·14 claims
- 0693US10464917B2Nicotine salts, co-crystals, and salt co-crystal complexesREYNOLDS TOBACCO CO R·Filed 2018·Granted Nov 5, 2019·7 cites·6 claims
- 0791US10865192B2Nicotine salts, co-crystals, and salt co-crystal complexesREYNOLDS TOBACCO CO R·Filed 2019·Granted Dec 15, 2020·8 cites·19 claims
- 0890US10851103B2Valbenazine salts and polymorphs thereofNEUROCRINE BIOSCIENCES INC·Filed 2020·Granted Dec 1, 2020·2 cites·27 claims
- 0990US10851104B2Valbenazine salts and polymorphs thereofNEUROCRINE BIOSCIENCES INC·Filed 2020·Granted Dec 1, 2020·2 cites·29 claims
- 1090US10844058B2Valbenazine salts and polymorphs thereofNEUROCRINE BIOSCIENCES INC·Filed 2020·Granted Nov 24, 2020·2 cites·27 claims
- 1184US7678785B2Substituted aniline derivativesUCB PHARMA SA·Filed 2007·Granted Mar 16, 2010·7 cites·22 claims
- 1282US8921544B2Oxazole tyrosine kinase inhibitorsSAREUM LTD·Filed 2014·Granted Dec 30, 2014·6 cites·14 claims
- 1379US9187465B2Oxazole tyrosine kinase inhibitorsSAREUM LTD·Filed 2014·Granted Nov 17, 2015·4 cites·8 claims
- 1478US12454517B2Nicotine salts, co-crystals, and salt co-crystal complexesREYNOLDS TOBACCO CO R·Filed 2021·Granted Oct 28, 2025·0 cites·20 claims
- 1577US8624022B2Substituted aniline derivativesCARR ANDREW DAVID·Filed 2011·Granted Jan 7, 2014·2 cites·8 claims
- 1675US2025163019A1Nicotine salts, co-crystals, and salt co-crystal complexesREYNOLDS TOBACCO CO R·Filed 2025·Application pending·0 cites
- 1774US12077518B2Nicotine salts, co-crystals, and salt co-crystal complexesREYNOLDS TOBACCO CO R·Filed 2020·Granted Sep 3, 2024·0 cites·27 claims
- 1871US8071582B2Substituted aniline derivativesCARR ANDREW DAVID·Filed 2010·Granted Dec 6, 2011·2 cites·20 claims
- 1967US7915300B2Cysteine protease inhibitorsMEDIVIR AB·Filed 2005·Granted Mar 29, 2011·1 cites·29 claims
- 2054US2013102592A1Oxazole tyrosine kinase inhibitorsSAREUM LTD·Filed 2012·Application pending·0 cites
- 2148US9650388B2Form 2 crystalline polymorph of a salt of N-[1-6-(ethynyl-3-oxo-hexahydro-furo[3,2-B]pyrrole-4-carbonyl)-3-methyl-butyl]-4-[5-fluoro-2-(4-methyl-piperazinyl) thiazol-4-yl]-benzamide useful as cysteine protease inhibitorMEDIVIR AB·Filed 2014·Granted May 16, 2017·0 cites·24 claims
- 2240US2011112089A1Cysteine Protease InhibitorsMEDIVIR AB·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Carr files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →